Capricorn Fund Managers’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
AIM
SLAM
Capricorn Fund Managers's PFE Position: Q2 2026 in Review
Capricorn Fund Managers reduced its Pfizer (PFE) stake by 87% in Q2 2026, selling an estimated $3.76M and leaving 22,130 shares worth $533K. The position accounts for 0.04% of the portfolio, ranked #152.
Capricorn Fund Managers first reported a position in PFE in Q4 2021 and has held it in 11 quarters since. The position peaked at $5.99M in Q3 2024. 1,440 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- Capricorn Fund Managers held 22,130 shares of Pfizer worth $533K as of Q2 2026.
- Capricorn Fund Managers sold 143,600 Pfizer shares in Q2 2026, an estimated $3.76M.
- Pfizer made up 0.04% of Capricorn Fund Managers's portfolio in Q2 2026, its #152 holding.
- Capricorn Fund Managers first reported a position in Pfizer in Q4 2021 and has held it in 11 quarters since.
- Capricorn Fund Managers's Pfizer position peaked at $5.99M in Q3 2024.
- 1,440 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on Capricorn Fund Managers's 13F filing for Q2 2026, filed 24 Jul 2026.